IP Library › Granted Patent US 11,511,009
Granted Patent B2
US 11,511,009 · App. 16/631,067 · Granted Nov 29, 2022

Filtered product bag with compact form factor

Inventors: William Spencer Hurst (Burlington, WI); Steven Clarence Jepson (Vernon Hills, IL); Grant Anthony Bomgaars (Kildeer, IL); Yuanpang Samuel Ding (Long Grove, IL); Thomas Edward Dudar (Palatine, IL); Ying-Cheng Lo (Long Grove, IL); Bernd Krause (Rangendingen, DE); Mark Edward Pasmore (Grayslake, IL); Michael Joseph Sadowski (Ringwood, IL); Anastasios Hristakos (Evanston, IL); Joseph Vincent Ranalletta (Greenville, SC)
Assignees: BAXTER INTERNATIONAL INC.; BAXTER HEALTHCARE SA
A61L2/26B65B3/003A61J1/10A61J1/1456A61L2/022A61L2202/121A61L2202/181A61L2202/21A61M2207/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,511,009
App. No.
16/631,067
Granted
Nov 29, 2022
Kind
B2
Abstract

A product bag includes a bladder and an elongated filtration device. The bladder includes opposing first and second film layers defining a product chamber. The first and second film layers are sealed together along a perimeter seal extending along at least a portion of a perimeter of the bladder. The elongated filtration device includes a housing, a filtration membrane disposed in the housing, an inlet adapted for receiving a fluid to be filtered, and an outlet in fluid communication with the product chamber. A majority of the elongated filtration device is embedded between the first and second film layers of the perimeter seal of the bladder to provide for a compact form factor.

Claims (10)

1. A method of sterilizing and introducing fluid into a product bag, the method comprising:

providing a bladder comprising opposing first and second film layers defining a sterile product chamber, the first and second film layers sealed together along a perimeter seal extending along at least a portion of a perimeter of the bladder, the perimeter seal including at least one break defining a bridging channel in fluid communication with the sterile product chamber;

providing a filtration device having an inlet end adapted for receiving a fluid to be sterilized, and an outlet end in fluid communication with the sterile product chamber via the bridging channel, the filtration device having a filter membrane with a nominal pore size in a range of approximately 0.1 μm to approximately 0.5 μm;

introducing a pharmaceutical fluid into the sterile product chamber through the filtration device and bridging channel such that a sterile pharmaceutical fluid resides within the sterile product chamber; and

sealing the opposing first and second film layers together across the bridging channel to create a bridge seal to maintain the sterilized pharmaceutical fluid in the sterile product chamber.

2. The method of claim 1 , further comprising cutting the filtration device off of the product bag.

3. The method of claim 2 , wherein the step of cutting the filtration device off of the product bag comprises cutting across the bridging seal.

4. The method of claim 2 , further comprising performing a filter integrity test on the filter membrane after the step of cutting the filtration device off of the product bag.

5. The method of claim 4 , wherein the step of performing the filter integrity test comprises performing one of a pressure degradation test, a bubble point test, a water intrusion test, or a water flow test.

6. The method of claim 1 , wherein the step of introducing the pharmaceutical fluid into the sterile product chamber through the filtration device comprises introducing the pharmaceutical fluid through a plurality of filter membranes.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 19, 2020
From: HURST, WILLIAM SPENCER; JEPSON, STEVEN CLARENCE; BOMGAARS, GRANT ANTHONY; DING, YUANPANG SAMUEL; DUDAR, THOMAS EDWARD; LO, YING-CHENG; KRAUSE, BERND; PASMORE, MARK EDWARD; SADOWSKI, MICHAEL JOSEPH; HRISTAKOS, ANASTASIOS; RANALLETTA, JOSEPH VINCENT
To: BAXTER INTERNATIONAL INC.; BAXTER HEALTHCARE SA
Reel/Frame 052986/0926 →
Continuity (2)
Provisional Application 62533427 · Jul 17, 2017
Related Publication 20200147251A1 · May 14, 2020